Dover Operating Cash Flow decreased by 64.9% to $191.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.3%, from $157.47M to $191.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 4.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $260.07M | $351.33M | $327.28M | $23.68M | $178.77M | $264.63M | $338.64M | $241.28M | $195.25M | $383.46M | $516.35M | $166.59M | $203.66M | $278.63M | $438.95M | $157.47M | $212.34M | $424.25M | $543.95M | $191.00M |
| QoQ Change | — | +35.1% | -6.8% | -92.8% | +654.9% | +48.0% | +28.0% | -28.7% | -19.1% | +96.4% | +34.7% | -67.7% | +22.3% | +36.8% | +57.5% | -64.1% | +34.8% | +99.8% | +28.2% | -64.9% |
| YoY Change | — | — | — | — | -31.3% | -24.7% | +3.5% | +918.8% | +9.2% | +44.9% | +52.5% | -31.0% | +4.3% | -27.3% | -15.0% | -5.5% | +4.3% | +52.3% | +23.9% | +21.3% |